Skip to main content
Equibles
ELTP logo

ELTP · Elite Pharmaceuticals Inc · Webcasts, Transcripts & Audio

Track ELTP — free

Use ELTP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ELTP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.25 0.00 (-0.12%) At close · Oct 21
Rebalance outlook locked
Going-concern doubt — cleared Aug 13, 2026

The latest filing no longer states the doubt (first flagged Jun 29, 2026).

View the 10-Q filed Aug 13, 2026
Market Cap
$269.28M
Shares
1.08B
Volume · Oct 21 223.38K Avg daily vol (3M) 771.66K

Elite Pharmaceuticals Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Elite Pharmaceuticals Inc (ELTP), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY27 · Q1
2026-08-14
Elite Pharmaceuticals Inc (ELTP) Q1 2027 Earnings Call
Revenue
$32.36M
▼ 19.5% YoY
Diluted EPS
$0.01
Gross margin
41.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q4
2026-06-30
Elite Pharmaceuticals Inc (ELTP) Q4 2026 Earnings Call
Revenue
$40.75M*
▲ 27.4% YoY
Gross margin
51.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-02-18
Elite Pharmaceuticals Inc (ELTP) Q3 2026 Earnings Call Transcript
Confident tone Revenue growth and milestones M&A and NASDAQ listing exploration Balance sheet and working capital
Revenue
$31.59M
▲ 119.9% YoY
Diluted EPS
$0.01
Gross margin
41.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-08-14
Elite Pharmaceuticals Inc (ELTP) Q1 2026 Earnings Call
Revenue
$40.21M
▲ 113.9% YoY
Diluted EPS
$-0.01
Gross margin
67.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q3
2025-02-13
Elite Pharmaceuticals Inc (ELTP) Q3 2025 Earnings Call
Revenue
$14.36M
▼ 7.6% YoY
Diluted EPS
$-0.01
Gross margin
42.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-11-14
Elite Pharmaceuticals Inc (ELTP) Q2 2025 Earnings Call
Revenue
$18.88M
▲ 33.4% YoY
Diluted EPS
$-0.01
▼ 200% YoY
Gross margin
43.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-07-01
Elite Pharmaceuticals Inc (ELTP) Q1 2025 Earnings Call
Revenue
$18.80M
▲ 109.4% YoY
Diluted EPS
$0.00
Gross margin
45.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-02-14
Elite Pharmaceuticals Inc (ELTP) Q3 2024 Earnings Call
Revenue
$15.54M
▲ 68% YoY
Diluted EPS
$0.00
Gross margin
45.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2023-11-14
Elite Pharmaceuticals Inc (ELTP) Q2 2024 Earnings Call
Revenue
$14.16M
▲ 64.9% YoY
Diluted EPS
$0.01
Gross margin
45.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-08-14
Elite Pharmaceuticals Inc (ELTP) Q1 2024 Earnings Call
Revenue
$8.98M
▲ 17% YoY
Diluted EPS
$0.00
Gross margin
52.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-06-29
Elite Pharmaceuticals Inc (ELTP) Q4 2023 Earnings Call
Revenue
$8.65M*
▲ 12.7% YoY
Gross margin
44.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-02-14
Elite Pharmaceuticals Inc (ELTP) Q3 2023 Earnings Call
Revenue
$9.25M
▲ 3.1% YoY
Diluted EPS
$0.00
Gross margin
53.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-11-15
Elite Pharmaceuticals Inc (ELTP) Q2 2023 Earnings Call
Revenue
$8.59M
▲ 0.3% YoY
Diluted EPS
$0.00
Gross margin
44.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-08-15
Elite Pharmaceuticals Inc (ELTP) Q1 2023 Earnings Call
Revenue
$7.67M
▲ 8.7% YoY
Diluted EPS
$0.00
Gross margin
52.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-06-29
Elite Pharmaceuticals Inc (ELTP) Q4 2022 Earnings Call
Revenue
$7.67M*
▲ 74.5% YoY
Gross margin
45.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-02-15
Elite Pharmaceuticals Inc (ELTP) Q3 2022 Earnings Call
Revenue
$8.97M
▲ 48.4% YoY
Diluted EPS
$0.00
Gross margin
44.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2021-11-15
Elite Pharmaceuticals Inc (ELTP) Q2 2022 Earnings Call
Revenue
$8.56M
▲ 15.7% YoY
Diluted EPS
$0.00
Gross margin
44.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-08-16
Elite Pharmaceuticals Inc (ELTP) Q1 2022 Earnings Call
Revenue
$7.06M
▼ 6.4% YoY
Diluted EPS
$0.00
Gross margin
50.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-06-14
Elite Pharmaceuticals Inc (ELTP) Q4 2021 Earnings Call
Revenue
$4.40M*
▼ 11.1% YoY
Gross margin
42.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-02-16
Elite Pharmaceuticals Inc (ELTP) Q3 2021 Earnings Call
Revenue
$6.05M
▲ 19.6% YoY
Diluted EPS
$0.00
Gross margin
56.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2020-11-16
Elite Pharmaceuticals Inc (ELTP) Q2 2021 Earnings Call
Revenue
$7.40M
▲ 59.7% YoY
Diluted EPS
$0.00
Gross margin
48.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-08-17
Elite Pharmaceuticals Inc (ELTP) Q1 2021 Earnings Call
Revenue
$7.54M
▲ 124.4% YoY
Diluted EPS
$0.00
Gross margin
39.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-06-29
Elite Pharmaceuticals Inc (ELTP) Q4 2020 Earnings Call
Revenue
$4.95M*
▲ 268% YoY
Gross margin
49.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-02-10
Elite Pharmaceuticals Inc (ELTP) Q3 2020 Earnings Call
Revenue
$5.06M
▲ 87.6% YoY
Diluted EPS
$0.00
Gross margin
57.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–24 of 24 webcasts
Key facts CIK 1053369 CUSIP 28659T200 Visit website Investor relations